Two neuraminidase inhibitors for treatment of influenza.
D000081:Acetamides / Q000627:therapeutic use; D000280:Administration, Inhalation; D000284:Administration, Oral; D000547:Amantadine / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011355:Prodrugs / Q000627:therapeutic use; D011714:Pyrans; D012794:Sialic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D000588:Amines; D000998:Antiviral Agents; D006146:Guanidines; D011355:Prodrugs; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D000547:Amantadine; D009439:Neuraminidase; D053243:Zanamivir